COPD合并肺动脉高压患者肺内5-羟色胺转运体增高
本研究首次用SERT选择性示踪剂[11C]DASB PET/CT活体评估COPD及COPD合并PH患者肺内SERT可用性。四组各5人,COPD与COPD+PH组经肺组织衰减校正后TTBR25-30均低于健康对照,而COPD+PH组高于单纯COPD组,且与PH严重程度正相关、与气流受限和肺气肿负相关,提示肺SERT参与COPD患者PH的发生。
要点
- COPD+PH患者经衰减校正的肺TTBR25-30显著高于单纯COPD患者。
- 衰减校正TTBR25-30与有创测量的PH严重程度正相关,与气流受限和肺气肿负相关。
- 全部COPD患者中TTBR25-30与右心 strain 指标NT-proBNP正相关。
核心结论
- COPD患者发展为PH时肺内[11C]DASB摄取增高,提示肺SERT可能参与COPD患者PH的发生。
研究设计与样本
- 本研究为四组各5名参与者的活体PET/CT研究,使用SERT选择性[11C]DASB行动态采集30分钟。
- 分组为COPD、COPD+PH、肺动脉高压和健康对照,基于中叶感兴趣区生成时间-活性曲线。
- 以25至30分钟组织-血浓度比(TTBR25-30)作为受体参数,并经肺组织衰减校正后比较。
主要发现
- 经肺组织衰减校正后,[11C]DASB摄取峰值在各队列间无差异,提示示踪剂递送相等。
- COPD和COPD+PH队列经衰减校正的TTBR25-30均显著低于健康对照。
- COPD+PH队列经衰减校正的TTBR25-30显著高于COPD队列,非吸烟者高于吸烟者。
- 衰减校正TTBR25-30与有创测量的PH严重程度正相关,与气流受限和肺气肿负相关。
- 全部COPD患者(±PH)中,衰减校正TTBR25-30与右心 strain 指标NT-proBNP正相关。
临床怎么用
- COPD患者可用[11C]DASB PET/CT半定量评估肺SERT可用性,辅助识别PH相关生物学改变。
- 解读肺SERT参数时需进行肺组织衰减校正,并考虑吸烟状态的影响。
局限性
- 每组仅5名参与者,样本量小。
- 原文未报告统计学检验的具体P值或置信区间。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Pulmonary hypertension (PH) is characterized by a progressive remodelling of the pulmonary vasculature resulting in right heart failure and eventually death. The serotonin transporter (SERT) may be involved in the pathogenesis of PH in patients with chronic-obstructive pulmonary disease (COPD). This study investigated for the first time the SERT in vivo availability in the lungs of patients with COPD and PH (COPD+PH). METHODS: SERT availability was assessed using SERT-selective [11C]DASB and positron emission tomography/computed tomography (PET/CT) with dynamic acquisition over 30 min in 4 groups of 5 participants each: COPD, COPD+PH, pulmonary arterial hypertension, and a healthy control (HC). Time activity curves were generated based on a volume of interest within the middle lobe. Tissue-to-blood concentration ratios after 25 to 30 min (TTBR25-30) served as receptor parameter for group comparison and were corrected for lung tissue attenuation. Participants underwent comprehensive pulmonary workup. Statistical analysis included group comparisons and correlation analysis. RESULTS: [11C]DASB uptake peak values did not differ among the cohorts after adjusting for lung tissue attenuation, suggesting equal radiotracer delivery. Both the COPD and COPD+PH cohort showed significantly lower TTBR25-30 values after correction for lung attenuation than HC. Attenuation corrected TTBR25-30 values were significantly higher in the COPD+PH cohort than those in the COPD cohort and higher in non-smokers than in smokers. They positively correlated with invasively measured severity of PH and inversely with airflow limitation and emphysema. Considering all COPD patients ± PH, they positively correlated with right heart strain (NT-proBNP). CONCLUSION: By applying [11C]DASB and PET/CT, semiquantitative measures of SERT availability are demonstrated in the lung vasculature of patients with COPD and/or PH. COPD patients who developed PH show increased pulmonary [11C]DASB uptake compared to COPD patients without PH indicating an implication of pulmonary SERT in the development of PH in COPD patients.
引用
- Frille A, Rullmann M, Becker GA, et al. Increased pulmonary serotonin transporter in patients with chronic obstructive pulmonary disease who developed pulmonary hypertension. Eur J Nucl Med Mol Imaging. 2020. PMID: 33009594. doi:10.1007/s00259-020-05056-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。